[1] Hosking SM, Dobbins AG, Pasco JA, et al.Knowledge change regarding osteoporosis prevention: translating recommended guidelines into user-friendly messages within a community forum[J]. BMC Res Notes, 2015, 8: 33-37. [2] 陈晓, 苏佳灿. 骨质疏松研究热点:骨髓间充质干细胞分化命运[J]. 第二军医大学学报, 2017, 38(4):397-404. [3] Kim KH, Roberts CW.Targeting EZH2 in cancer[J]. Nat Med, 2016, 22(2): 128-134. [4] Jing H, Li L, An Y, et al.Suppression of EZH2 prevents the shift of ssteoporotic MSC fate to adipocyte and enhances bone formation during osteoporosis[J]. Mol Ther, 2016, 24(2): 217-229. [5] Panahi Y, Ahmadi Y, Teymouri M, et al.Curcumin as a potential candidate for treating hyperlipidemia: a review of cellular and metabolic mechanisms[J]. J Cell Physiol, 2018, 233(1): 141-152. [6] Li G, Bu J, Zhu Y, et al.Curcumin improves bone microarchitecture in glucocorticoid-induced secondary osteoporosis mice through the activation of microRNA-365 via regulating MMP-9[J]. Int J Clin Exp Pathol, 2015, 8(12): 15684-15695. [7] Ahn J, Jeong J, Lee H, et al.Poly (lactic-co-glycolic acid) nanoparticles potentiate the protective effect of curcumin against bone loss in ovariectomized rats[J]. J Biomed Nanotechnol, 2017, 13(6): 688-698. [8] Hussan F, Ibraheem NG, Kamarudin TA, et al.Curcumin protects against ovariectomy-induced bone changes in rat model[J]. Evid Based Complement Alternat Med, 2012, 2012: 174916. [9] Zheng X, Zhang Y, Guo S, et al.Dynamic expression of matrix metalloproteinases 2, 9 and 13 in ovariectomy induced osteoporosis rats[J]. Exp Ther Med, 2018, 16(3): 1807-1813. [10] Lelovas PP, Xanthos TT, Thoma SE, et al.The laboratory rat as an animal model for osteoporosis research[J]. Comp Med, 2008, 58(5): 424-430. [11] Riva A, Franceschi F, Togni S, et al.Health benefits of curcumin and curcumin phytosome in bone density disorders[J]. Bone Marrow Res, 2017, 1(2): 1006-1009. [12] Guo C, Li C, Yang K, et al.Increased EZH2 and decreased osteoblastogenesis during local irradiation-induced bone loss in rats[J]. Sci Rep, 2016, 6: 31318. [13] Bhan A, Hussain I, Ansari KI, et al.Histone methyltransferase EZH2 is transcriptionally induced by estradiol as well as estrogenic endocrine disruptors bisphenol-A and diethylstilbestrol[J]. J Mol Biol, 2014, 426(20): 3426-3441. [14] Hemming S, Cakouros D, Isenmann S, et al.EZH2, and KDM6A, act as an epigenetic switch to regulate mesenchymal stem cell lineage specification[J]. Stem Cells, 2014, 32(3): 802-815. [15] Fang C, Yu Q, Mun SH, et al.Cutting Edge: EZH2 promotes osteoclastogenesis by epigenetic silencing of the negative regulator IRF8[J]. J Immunol, 2016, 196(11): 4452-4456. [16] Shang W, Zhao LJ, Dong XL, et al.Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways[J]. Mol Med Rep, 2016, 14(4): 3620-3626. |